相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
Qiao Li et al.
CANCER BIOLOGY & THERAPY (2015)
Prediction of Cancer Incidence and Mortality in Korea, 2015
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Chemotherapy in Patients with Anthracycline and Taxane-Pretreated Metastatic Breast Cancer: An Overview
Eleni Andreopoulou et al.
CURRENT BREAST CANCER REPORTS (2013)
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2012)
Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience
M. Ozkan et al.
NEOPLASMA (2012)
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
L. Staudacher et al.
ANNALS OF ONCOLOGY (2011)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
Alvaro Moreno-Aspitia et al.
MAYO CLINIC PROCEEDINGS (2009)
Platinum-based chemotherapy in triple-negative breast cancer
B. Sirohi et al.
ANNALS OF ONCOLOGY (2008)
Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes
Berna Oeksuezoglu et al.
CHEMOTHERAPY (2008)
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
Eva S. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer
H. L. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer
Cristian Massacesi et al.
ONCOLOGY (2006)
Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes
M Donadio et al.
ONCOLOGY (2005)
Platinum-based chemotherapy in metastatic breast cancer: current status
MP Decatris et al.
CANCER TREATMENT REVIEWS (2004)
The platinum agents: A role in breast cancer treatment?
JP Crown
SEMINARS IN ONCOLOGY (2001)
分享论文
